SMARC A4/BRG1 Deficient Lung Carcinoma Complicated by Treatment Related Immune-Mediated Pneumonitis

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.